Search for: "MYLAN LABORATORIES LIMITED" Results 1 - 20 of 94
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Mar 2021, 1:15 pm by Logan Murr
Court of Appeals for the Federal Circuit (CAFC) granted Janssen Pharmaceuticals’ motion to dismiss Mylan Laboratories’ appeal and denied Mylan Laboratories’ request for mandamus relief, holding that the court lacked jurisdiction to hear Mylan’s appeal and that Mylan had failed to qualify for mandamus relief. [read post]
10 Nov 2020, 2:01 am by Courtenay C. Brinckerhoff
” The Venue Dispute At Issue As noted in the Federal Circuit decision, defendant Mylan Pharmaceuticals Inc. is a West Virginia corporation with a principal place of business in Morgantown, West Virginia; defendant Mylan Inc. is a Pennsylvania corporation with a principal place of business in Canonsburg, Pennsylvania, and defendant Mylan Laboratories Ltd. [read post]
17 Aug 2020, 8:37 am by Rebecca Tushnet
Again as alleged: At that time, defendant manufacturers’ products violated three of those factors: (1) their prescription pet food included indications of disease claims on the labels; (2) the distribution of promotional materials with disease claims were not limited to veterinary professionals; (3) they electronically disseminated promotional materials with disease claims to consumers on the internet. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
AMSORB PLUS PREFILLED G-CAN 1.0L canisters have been recalled by Armstrong Medical Limited due to the risk of reduced airflow to patients. [read post]
24 Dec 2018, 6:08 am by Robert Kraft
The Food and Drug Administration said Tuesday, “Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
1 Dec 2017, 2:53 pm by Gregory B. Williams
Mylan Laboratories Limited et al., Civil Action No. 16-224-LPS (D.Del., December 1, 2017), the Court denied without prejudice the motion to dismiss for improper venue or, in the alternative, to transfer venue to the Northern District of West Virginia of Defendant Mylan Laboratories Limited, Mylan, Inc. and Mylan Pharmaceutical Inc. [read post]
2 Jul 2017, 12:52 am
That lower courts had answered that question with the reply - the "promise of the patent" (Pfizer v  Mylan (2011 FC 547). [read post]
1 Jul 2017, 9:39 am
That lower courts had answered that question with the reply - the "promise of the patent" (Pfizer v  Mylan (2011 FC 547). [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]